
CAR-T is emerging as one of the most potentially exciting therapies in the industry, particularly as a beacon for the …

Ziopharm Oncology has issued a statement following the death of a patient enrolled on a Phase I clinical trial for …
Boyds expands Regulatory Affairs team to support growing demand
Sterling doubles ADC manufacturing capacity at Welsh facility
Femtosecond laser cuts lung tumour margin assessment time
Blood sensor detects Parkinson’s-associated proteins in 40 minutes

